ENTERA BIO LTD. Income Taxes Paid
ENTERA BIO LTD. (ENTX) reported Income Taxes Paid of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2023-11-14
- 2023-09-30: Income Taxes Paid 9 month $0.00.
- 2022-09-30: Income Taxes Paid 9 month $165.00K.
| Period end | Income Taxes Paid 9 month |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2022-09-30 | $165.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |